MetaCap

CryoPort Quarterly Balance Sheet

NASDAQ: CYRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

17.35+0.45 (+2.66%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

CryoPort financial position

As of Jun 30, 2026, CryoPort reported total assets of $756.2 million, down 2.3% from a year earlier against total liabilities of $265.5 million. Shareholders' equity stood at $490.7 million, or 64.9% of assets. The company held $269.3 million in cash and equivalents against $985,000 of debt, a net cash position of $268.3 million.

The current ratio (current assets divided by current liabilities) was 2.08, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.00.

Summary generated from market data by MetaCap's automated system. Methodology

CryoPort balance sheet (quarterly)

CryoPort quarterly balance sheet
Quarter (USD)Q2 20262026-06-30Q1 20262026-03-31Q4 20252025-12-31Q3 20252025-09-30Q2 20252025-06-30Q1 20252025-03-31Q4 20242024-12-31Q3 20242024-09-30Q2 20242024-06-30Q1 20242024-03-31Q4 20232023-12-31Q3 20232023-09-30
Cash & Equivalents269.27M272.91M250.49M255.81M243.42M36.10M34.14M31.37M34.18M39.29M35.19M59.47M
Short-Term Investments127.43M130.72M160.71M165.50M182.56M207.93M216.46M228.00M380.68M398.88M410.41M406.39M
Receivables36.45M39.00M33.36M34.91M33.41M28.37M25.30M43.46M40.16M41.25M42.07M42.63M
Inventory21.51M21.75M23.19M23.33M23.04M23.34M21.48M23.55M23.61M25.02M26.21M29.10M
Total Current Assets460.20M470.54M476.17M484.84M489.49M411.28M341.57M350.34M501.99M525.70M535.11M549.14M
Property, Plant & Equipment94.52M89.81M85.45M83.23M81.56M80.48M80.01M88.28M86.65M86.01M84.86M74.52M
Goodwill22.07M22.14M22.40M22.41M18.71M20.96M20.57M54.06M52.38M107.59M76.39M148.95M
Intangible Assets135.99M138.72M138.08M141.25M143.59M145.41M147.93M175.81M178.39M190.09M194.38M192.96M
Total Assets756.20M763.61M764.99M774.33M773.93M699.84M703.49M701.76M852.34M942.85M957.74M1.00B
Accounts Payable16.25M15.94M15.28M13.88M14.76M13.44M15.89M25.19M24.80M27.38M27.00M27.88M
Total Current Liabilities221.04M224.87M219.02M30.75M30.15M74.03M64.56M61.44M59.88M48.98M45.61M44.91M
Long-Term Debt985.00K1.03M1.09M1.29M1.33M1.12M1.11M1.24M1.26M1.30M1.33M307.00K
Total Liabilities265.50M268.62M262.35M261.06M258.54M301.03M301.59M283.19M452.25M470.66M468.72M463.13M
Shareholders' Equity490.70M494.99M502.64M513.27M519.08M398.81M401.90M418.57M400.10M472.19M489.02M537.53M
Retained Earnings-707.68M-699.43M-688.88M-675.24M-668.24M-769.16M-757.17M-738.50M-739.30M-661.31M-642.42M-580.03M
Total Debt985.00K1.03M1.09M1.29M1.33M1.12M1.11M1.24M1.26M1.30M1.33M307.00K
Net Cash (Debt)395.71M402.61M410.12M420.02M424.65M242.91M249.48M258.13M413.61M436.87M444.27M465.56M
Shares Outstanding50.65M50.20M49.85M50.07M50.28M50.14M49.91M49.43M49.41M49.26M48.97M48.96M

This table shows 12 quarterly periods of CryoPort's balance sheet, from Q2 2026 back to Q3 2023, across 18 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow CYRX's reporting calendar. What is a balance sheet?

More financial data